Appili Therapeutics Inc (PK) (APLIF)
USOTC
Year End March 30 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 2.17M | 886k | 1.29M | 2.45M | 472k | 6.71M |
Operating Income | -4.37M | -5.4M | -14.37M | -23.56M | -7.78M | -2.16M |
Pre Tax Income | -4.33M | -5.42M | -14.33M | -25.08M | -9.21M | -3.71M |
Net Income | -4.33M | -5.42M | -14.33M | -25.12M | -9.24M | -3.78M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.552 | -0.117 | -0.228 | -0.352 | -0.076 | -0.031 |
EBIT | -4.37M | -5.4M | -14.37M | -23.56M | -7.78M | -2.16M |
EBITDA | -4.35M | -5.39M | -14.36M | -23.55M | -7.77M | -2.15M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.